SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001193125-18-096123
Filing Date
2018-03-26
Accepted
2018-03-26 17:18:13
Documents
2

Document Format Files

Seq Description Document Type Size
1 424B5 d555650d424b5.htm 424B5 271123
2 GRAPHIC g555650g80u98.jpg GRAPHIC 38384
  Complete submission text file 0001193125-18-096123.txt   325120
Mailing Address 245 FIRST STREET SUITE 1100 CAMBRIDGE MA 02142
Business Address 245 FIRST STREET SUITE 1100 CAMBRIDGE MA 02142 617-871-2098
Akebia Therapeutics, Inc. (Filer) CIK: 0001517022 (see all company filings)

IRS No.: 208756903 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-223585 | Film No.: 18713503
SIC: 2834 Pharmaceutical Preparations